Loading...
NPI 1285014282 · Overland Park, KS · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America Holdings is a clinical medical laboratory provider located in Overland Park, Kansas. This profile covers 370 Medicare and 253 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America Holdings |
| Address | 7800 W 110th St |
| City | Overland Park |
| State | KS |
| ZIP | 66210 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 4, 2015 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $26.1M |
| Medicare | $8.5M |
Laboratory profile and service lines: LABORATORY CORPORATION OF AMERICA HOLDINGS is operating as a high-volume clinical laboratory focused on routine chemistry, endocrine, hematology, and specimen-collection services—Medicare top codes include 80053 (CMP), 84443 (TSH), 80061 (lipid panel), 85025 (CBC), and 36415 (venipuncture). The mixture of high counts for panel codes and for 36415 indicates a centralized reference-lab model that processes very large numbers of outpatient specimens rather than a low-volume, clinic-based draw site.
Medicare revenue concentration: This provider reported $8.5M in total Medicare revenue, with the precomputed top-3 Medicare codes accounting for 38.6% of that Medicare revenue; the listed Medicare leaders include 80053 ($856.5K), 84443 ($810.6K), and 80061 ($800K). The concentration in a small set of routine chemistry and endocrine panels shows that a material share of Medicare dollars flows from high-throughput, standardized tests rather than a broad mix of niche assays.
Medicaid scale and payer mix: Medicaid is the larger payer for this entity, with $26.1M in total Medicaid revenue versus $8.5M in Medicare, so the provider is effectively Medicaid-dominant by scale. The precomputed top-3 Medicaid codes account for 22.1% of Medicaid revenue, with high individual Medicaid-line items like 87491 ($1.5M), 87591 ($1.4M), and 84443 ($1.4M) signaling both infectious disease NAAT volume and routine endocrine testing as sizable revenue drivers.
National competitive standing on Medicare: For many of the routine Medicare codes this provider reports extreme national volume—examples include 80053 ($856.5K, rank #48 of 26416, 100th percentile; extreme outlier), 84443 ($810.6K, rank #39 of 19722, 100th percentile; extreme outlier), and 80061 ($800K, rank #42 of 21671, 100th percentile; extreme outlier). These rank/label patterns indicate the provider is a national-volume outlier for common lab tests and competes at scale for high-frequency diagnostic chemistry and endocrine assays.
In-state competitive standing on Medicaid: The provider consistently ranks at or near the top among in-state peers for high-volume Medicaid codes—87491 and 87591 rank #2 in-state (98th percentile) and multiple common panels (80061, 80053, 85025, 82306, 83036) also rank in the 97–99th percentiles and are described as notably above typical state volume. The presence of 81220 (CFTR) at $926.8K and ranked #1 of 2 providers in-state (100th percentile) further indicates the lab provides specialized genetic testing capacity that few in-state competitors match.
Mix of routine and higher-complexity testing: Beyond routine panels, the Medicaid mix contains higher-cost molecular and genomic items—81420 (cfDNA) generated $1.1M and 81220 (CFTR) $926.8K—while definitive drug-testing codes G0480/G0481 and other molecular assays appear in the top-25 Medicaid list. This combination of high-volume low-unit-price testing (panels) and nontrivial revenue from specialized assays suggests an operating footprint that supports both large-scale screening and selected advanced diagnostics.
Unit economics and throughput signal: Many of the highest-volume codes show low average paid per claim (e.g., 80053 $10 avg paid/claim with 85.7K claims on Medicare and 80061 $13 avg paid/claim with 61.5K claims), while specimen-collection code 36415 appears among the top Medicare codes with 89.6K claims. The pairing of very large claim counts and modest per-claim payments is consistent with a high-throughput lab processing model where scale and specimen volume drive revenue rather than high per-test prices.
Tenure and market implications: The NPI was enumerated 2015-06-04 (~11 years ago), indicating an established presence long enough to achieve the reported national and state scale. Combined with the extreme-outlier national ranks on routine Medicare codes and top-in-state placement on many Medicaid codes, the tenure supports the conclusion that this provider has become an entrenched, high-volume participant in both reference lab processing and select specialty testing within its markets.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
370 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 85,650 | $10 | $856.5K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 50,660 | $20 | $810.6K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 61,540 | $10 | $800K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 89,630 | $10 | $717.1K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 70,790 | $10 | $566.3K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 17,290 | $30 | $501.5K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 36,960 | $10 | $369.6K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 4,910 | $40 | $196.2K |
| 84439 | The lab analyst performs a test to measure free thyroxine, or free T4, typically in patient serum. | 19,580 | $10 | $176.2K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 10,820 | $20 | $162.3K |
Showing 1–10 of 370
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 370 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
370 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81479 | 3 | 10 | 1,140 | $2,270 | $4.5M |
| G0483 | 3 | 10 | 440 | $240 | $248.4K |
| G0481 | 3 | 10 | 150 | $150 | $160.5K |
| G0480 | 3 | 10 | 140 | $110 | $160.3K |
| 86480 | 2 | 10 | 540 | $60 | $105.6K |
| G0472 | 2 | 10 | 1,080 | $50 | $99.9K |
| 87088 | 3 | 10 | 1,140 | $10 | $89.8K |
| 83521 | 2 | 10 | 1,580 | $20 | $83.5K |
| 86003 | 3 | 10 | 2,870 | $10 | $69.7K |
| 83698 | 2 | 10 | 1,490 | $40 | $66.6K |
Showing 1–10 of 370
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
253 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 61,040 | $20 | $1.5M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 62,680 | $20 | $1.4M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 142,690 | $10 | $1.4M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 168,940 | $10 | $1.4M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 212,170 | $10 | $1.3M |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 63,500 | $20 | $1.1M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 2,930 | $370 | $1.1M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 205,520 | $10 | $1M |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 2,750 | $340 | $926.8K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 33,780 | $30 | $911.9K |
Showing 1–10 of 253
How this provider's Medicaid billing volume and revenue compare to other Kansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kansas median
253 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 2 | 10 | 5,450 | $440 | $2.4M |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 2 | 10 | 2,130 | $60 | $1.1M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 2 | 10 | 140 | $40 | $854.5K |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 1 | 10 | 2,290 | $330 | $763.3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 14 | 50 | 300 | $60 | $648.3K |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 2 | 10 | 430 | $50 | $478.6K |
| 83013 | The lab analyst tests multiple breath samples for the presence of an isotope that indicates the presence of the H. pylori bacteria. This organism can cause irritation and ulcers of the stomach lining. | 4 | 10 | 550 | $50 | $468K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 2 | 10 | 2,640 | $150 | $399.4K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 5 | 10 | 1,000 | $50 | $385.6K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 2 | 20 | 120 | $20 | $375.6K |
Showing 1–10 of 253
Other providers in the same ZIP code as Laboratory Corporation Of America Holdings, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Maxim Healthcare Services, Inc. | KS | Home Health Agency | $0 | $64.4M |
| Maxim Healthcare Services,inc. | KS | Home Health Agency | $0 | $23.5M |
| Moore Enterprises | KS | Home Health Agency | $0 | $16M |
| Carestaf, Inc. | KS | Home Health Agency | $0 | $10.4M |
| Laboratory Corporation Of America Holdings | KS | Clinical Medical Laboratory | $806.3K | $6.6M |
| Intelligere LLC | KS | Interpreter | $0 | $6.5M |
| Homestead Of Overland Park Operations LLC | KS | Assisted Living Facility | $0 | $2.4M |
| In Home Family Counseling Associates LLC | KS | Marriage & Family Therapist | $0 | $1.8M |
| Vpa PC | KS | Family Medicine Physician | $0 | $1.2M |
| Shirley Wang | KS | Rheumatology Physician | $1.2M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.